Teladoc Health, Inc.
TDOC
$5.35
-$0.17-3.08%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 642.27M | 626.44M | 631.90M | 629.37M | 640.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 642.27M | 626.44M | 631.90M | 629.37M | 640.49M |
| Cost of Revenue | 197.05M | 187.18M | 190.54M | 196.83M | 188.93M |
| Gross Profit | 445.22M | 439.26M | 441.36M | 432.54M | 451.56M |
| SG&A Expenses | 305.74M | 318.78M | 325.61M | 329.65M | 327.45M |
| Depreciation & Amortization | 94.84M | 88.37M | 93.00M | 87.87M | 89.52M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 669.24M | 661.90M | 677.94M | 684.31M | 682.65M |
| Operating Income | -26.97M | -35.46M | -46.04M | -54.94M | -42.16M |
| Income Before Tax | -33.62M | -50.22M | -40.42M | -111.27M | -48.17M |
| Income Tax Expenses | -8.48M | -715.00K | -7.76M | -18.26M | 238.00K |
| Earnings from Continuing Operations | -25.14M | -49.51M | -32.66M | -93.01M | -48.41M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.14M | -49.51M | -32.66M | -93.01M | -48.41M |
| EBIT | -26.97M | -35.46M | -46.04M | -54.94M | -42.16M |
| EBITDA | 28.67M | 10.68M | 2.68M | -8.96M | 11.78M |
| EPS Basic | -0.14 | -0.28 | -0.19 | -0.53 | -0.28 |
| Normalized Basic EPS | -0.09 | -0.12 | -0.11 | -0.16 | -0.15 |
| EPS Diluted | -0.14 | -0.28 | -0.19 | -0.53 | -0.28 |
| Normalized Diluted EPS | -0.09 | -0.12 | -0.11 | -0.16 | -0.15 |
| Average Basic Shares Outstanding | 177.83M | 176.93M | 175.92M | 174.15M | 172.77M |
| Average Diluted Shares Outstanding | 177.83M | 176.93M | 175.92M | 174.15M | 172.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |